Ginger L. Graham, Director at AMYLIN PHARMACEUTICALS INC (AMLN), sold 908 shares at $31.98 ($29K) on 2008-02-04, disclosed to the SEC on 2008-02-06.
Open-market sale of $29k AMLN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AMLN | SELL | 2007-08-07 | $1.0M | — | Filing → |